G&S Capital’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Sell
599
-177
-23% -$65.6K 0.07% 143
2026
Q1
$210K Sell
776
-8,733
-92% -$2.6M 0.07% 131
2025
Q4
$3.14M Sell
9,509
-200
-2% -$67.8K 1.11% 32
2025
Q3
$3.35M Buy
+9,709
New +$2.94M 1.24% 21
2023
Q2
Sell
-5,625
Closed -$2.66M 132
2023
Q1
$2.66M Sell
5,625
-1,919
-25% -$926K 1.18% 21
2022
Q4
$4M Buy
7,544
+284
+4% +$150K 1.77% 10
2022
Q3
$3.67M Buy
7,260
+1,745
+32% +$918K 1.95% 13
2022
Q2
$2.83M Buy
+5,515
New +$2.77M 1.67% 19

Other funds holding UNH

G&S Capital's UNH Position: Q2 2026 in Review

G&S Capital reduced its UnitedHealth (UNH) stake by 23% in Q2 2026, selling an estimated $65.6K and leaving 599 shares worth $249K. The position accounts for 0.07% of the portfolio, ranked #143.

G&S Capital first reported a position in UNH in Q2 2022 and has held it in 8 quarters since. The position peaked at $4M in Q4 2022. 1,542 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • G&S Capital held 599 shares of UnitedHealth worth $249K as of Q2 2026.
  • G&S Capital sold 177 UnitedHealth shares in Q2 2026, an estimated $65.6K.
  • UnitedHealth made up 0.07% of G&S Capital's portfolio in Q2 2026, its #143 holding.
  • G&S Capital first reported a position in UnitedHealth in Q2 2022 and has held it in 8 quarters since.
  • G&S Capital's UnitedHealth position peaked at $4M in Q4 2022.
  • 1,542 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on G&S Capital's 13F filing for Q2 2026, filed 10 Jul 2026.